Literature DB >> 16617297

Does recombinant adeno-associated virus-vectored proximal region of mouse rhodopsin promoter support only rod-type specific expression in vivo?

Lyudmyla G Glushakova1, Adrian M Timmers, Tawfik M Issa, Nenita G Cortez, Jijing Pang, Jacqueline T Teusner, William W Hauswirth.   

Abstract

PURPOSE: We have previously found that the -385 to +86 portion of the mouse rod opsin promoter (mOP500) can limit recombinant adeno-associated virus (rAAV)-mediated transgene expression to photoreceptor cells when delivered subretinally. However, the photoreceptor (PR) subtype-specificity of expression remains unclear. Here, we evaluated whether the presence of certain cis-elements in this proximal promoter, such as the rod-specific, neural retina leucine zipper protein (NRL) response element (NRE), can render it a driver of rod-specific expression.
METHODS: Subretinal injections of a serotype 5 rAAV vector carrying the green fluorescent protein (GFP) cDNA, driven by mOP500, were administered to male Sprague-Dawley rats at postnatal day (P) 40-48. Two weeks to eight months later, the distribution of GFP-expressing cells in the retina was characterized by GFP-, cone-specific alpha-transducin-immuno-, and peanut agglutinin-lectin histochemistry and by morphological criteria. The same viral suspension was also injected sub-retinally into rhodopsin-knockout rho (-/-) mice either at P18 or P78, and retinas were analyzed by immunohistochemistry and PNA lectin histochemistry two weeks later.
RESULTS: GFP reactivity was found exclusively in the outer nuclear layer (ONL) of rat retinas two weeks after treatment, with abundant reporter gene expression observed in both rods and cones. GFP-positive cones, defined by their typical morphology and the co-linearity of PNA-lectin labeling with GFP-immunoreactivity, were found in all regions of the transduced retinas. GFP-positive cones constituted up to 6% of the total GFP-positive photoreceptors. By eight months post-injection, a low level of GFP-reactivity was additionally observed in the inner nuclear layer (INL) and ganglion cell layer. Photoreceptor-specific GFP expression was also seen in the rho (-/-) mice at both ages tested. In pups injected at P18, costaining with PNA-lectin revealed that up to 15% of the GFP-positive photoreceptors were cones. Despite only a single row of photoreceptors remaining in these knockout mice by P90, numerous GFP-positive cones were still present.
CONCLUSIONS: Subretinal delivery of rAAV5 harboring a reporter gene driven by mOP500 results in passenger gene expression in both rod and cones, indicating that this promoter is photoreceptor-specific but not rod-specific. The lack of photoreceptor subtype-specificity suggests that although cones do not express the NRL and NR2E3 trans-factors considered necessary for activation of mOP500, other general transcription factors in cones may compensate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617297

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  12 in total

1.  A 350 bp region of the proximal promoter of Rds drives cell-type specific gene expression.

Authors:  Xue Cai; Shannon M Conley; Tong Cheng; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Exp Eye Res       Date:  2010-05-04       Impact factor: 3.467

2.  Varying the GARP2-to-RDS Ratio Leads to Defects in Rim Formation and Rod and Cone Function.

Authors:  Dibyendu Chakraborty; Shannon M Conley; Marci L DeRamus; Steven J Pittler; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 3.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886

4.  Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa.

Authors:  Xue Cai; Shannon M Conley; Zack Nash; Steven J Fliesler; Mark J Cooper; Muna I Naash
Journal:  FASEB J       Date:  2009-12-01       Impact factor: 5.191

5.  rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promoters.

Authors:  W A Beltran; S L Boye; S E Boye; V A Chiodo; A S Lewin; W W Hauswirth; G D Aguirre
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

6.  Functional and behavioral restoration of vision by gene therapy in the guanylate cyclase-1 (GC1) knockout mouse.

Authors:  Shannon E Boye; Sanford L Boye; Jijing Pang; Renee Ryals; Drew Everhart; Yumiko Umino; Andy W Neeley; Joseph Besharse; Robert Barlow; William W Hauswirth
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

7.  DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.

Authors:  Zongchao Han; Shannon M Conley; Rasha S Makkia; Mark J Cooper; Muna I Naash
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

Review 8.  Gene augmentation for adRP mutations in RHO.

Authors:  Alfred S Lewin; Brian Rossmiller; Haoyu Mao
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-18       Impact factor: 6.915

Review 9.  Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-28       Impact factor: 6.915

10.  Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors.

Authors:  Mariacarmela Allocca; Claudio Mussolino; Maria Garcia-Hoyos; Daniela Sanges; Carolina Iodice; Marco Petrillo; Luk H Vandenberghe; James M Wilson; Valeria Marigo; Enrico M Surace; Alberto Auricchio
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.